康臣药业10月23日斥资629.41万港元回购42.2万股
CONSUN PHARMACONSUN PHARMA(HK:01681) Zhi Tong Cai Jing·2025-10-23 10:26

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Category Company Actions - 康臣药业 plans to repurchase 422,000 shares at a total cost of HKD 6.2941 million [1] - The buyback price ranges from HKD 14.74 to HKD 15.04 per share [1] Financial Implications - The total expenditure for the buyback reflects a strategic move to enhance shareholder value [1]